Zydus Lifesciences Limited has announced its audited financial results for the quarter and year ended March 31, 2026. The company reported a 16.2% year-on-year increase in revenue from operations to Rs. 75,870 mn for Q4 FY26, while net profit rose 8.7% to Rs. 12,725 mn. For the full year FY26, revenue grew 16.8% to Rs. 2,71,484 mn and net profit increased 11.4% to Rs. 50,400 mn.

Key Board Decisions

The Board of Directors approved the audited financial results and recommended a dividend of Re. 1 per equity share (100%) for FY2025-26, subject to shareholder approval at the Annual General Meeting scheduled for August 11, 2026. The Board also approved a buyback of equity shares for an aggregate amount up to Rs. 11,000 mn at a price of Rs. 1,150 per share.

Operational Performance

EBITDA for Q4 FY26 stood at Rs. 25,544 mn, a 20.2% increase from the previous year, with margins expanding by 110 basis points to 33.7%. R&D investments for the quarter were Rs. 6,982 mn, accounting for 9.2% of revenues. The Consumer Wellness business led growth with a 61.1% YoY increase, while the India Formulations business grew 14% YoY.

The company noted that adjusted profit for the quarter excluded exceptional expenses related to a Mirabegron litigation settlement and impairment charges. Net Debt to Equity ratio as of March 31, 2026, was 0.16x.

Zydus Lifesciences Limited has announced that its Board of Directors has approved a proposal to buyback up to 95,65,217 fully paid-up equity shares. This represents 0.95% of the total paid-up equity share capital at a price of ₹1,150 per share. The aggregate buyback size amounts to ₹1,100 crore, and the transaction will be conducted via the tender offer route.

The Board has fixed May 29, 2026, as the record date to determine the eligibility of shareholders entitled to participate in the buyback. The offer is proposed to be made from all equity shareholders, including the promoter group, on a proportionate basis. The buyback size constitutes 5.16% and 3.84% of the aggregate of the fully paid-up equity share capital and free reserves as per the latest audited standalone and consolidated financial statements as of March 31, 2026, respectively.

Buyback Details

The key parameters of the buyback are outlined below:

Shareholding Pattern

The pre-buyback shareholding pattern as of May 15, 2026, indicates a strong promoter holding. The promoter and promoter group hold 74.9950% of the total equity shares, while mutual funds and foreign portfolio investors hold 4.8978% and 6.8586%, respectively.

The Board has also formed a buyback committee to oversee the process. The public announcement and letter of offer detailing the process and timelines will be released in due course.